Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions

Translational research(2021)10.1016/j.trsl.2021.11.006Source: DataRank Database

Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions is a research paper published in Translational research (2021). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.11)OA: bronzeTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Joanna Donatelli,Timothy J. Henrich ORCID,Michael J. Peluso ORCID

Live enrichment

PubMed:34780969 PMC:PMC8588584 OpenAlex:https://openalex.org/W3212307303

NIAID NIH HHS

Grant: K23 AI157875

NIAID NIH HHS

Grant: T32 AI060530

NIAID NIH HHS

Grant: L30 AI147159

National Institutes of Health

Grant: 5K23AI157875-02

Characterizing the virologic and immunologic signatures of HIV exceptional control

National Institutes of Health

Grant: 5R01AI141003-04

Targeting Non Viral Markers of HIV Persistence

FWCI

1.11

Citation Percentile

0.8%

Influential Citations

Citation Trend

2022

2023

2024

2025

bronzeLicense: Elsevier TDM

journalhttp://www.translationalres.com/article/S1931524421002693/pdf

GREENhttps://escholarship.org/content/qt0047x4p4/qt0047x4p4.pdf?t=rfdoiu

publisherhttp://www.translationalres.com/article/S1931524421002693/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1931524421002693?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931524421002693?httpAccept=text/plain

Fields of Study

SARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research StudiesMedicineBiology0301 basic medicine03 medical and health sciencesCOVID-19HumansSARS-CoV-2Translational Research, BiomedicalPost-Acute COVID-19 Syndrome

MeSH Terms

COVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeHumansTranslational Research, Biomedical

Keywords

PandemicImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Translational researchImmune systemMedicineCoronavirus disease 2019 (COVID-19)ImmunityIntensive care medicineInfectious disease (medical specialty)DiseaseBiomedicalCoronavirusesClinical SciencesCoronaviruses VaccinesReview ArticleVaccine RelatedTranslational Research, BiomedicalPost-Acute COVID-19 SyndromeBiodefenseHumansLungGeneral Clinical MedicineBiomedical and Clinical SciencesSARS-CoV-2PreventionCOVID-19PneumoniaCoronaviruses Disparities and At-Risk PopulationsInfectious DiseasesEmerging Infectious DiseasesGood Health and Well BeingMedical MicrobiologyBiochemistry and cell biologyImmunizationInfection

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being